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OBJECTIVE: To propose and test the applicability of a dysphonia risk screening protocol with score calculation in
individuals with and without dysphonia.
METHOD: This descriptive cross-sectional study included 365 individuals (41 children, 142 adult women, 91 adult men
and 91 seniors) divided into a dysphonic group and a non-dysphonic group. The protocol consisted of 18 questions
and a score was calculated using a 10-cm visual analog scale. The measured value on the visual analog scale was
added to the overall score, along with other partial scores. Speech samples allowed for analysis/assessment of the
overall degree of vocal deviation and initial definition of the respective groups and after six months, the separation
of the groups was confirmed using an acoustic analysis.
RESULTS: The mean total scores were different between the groups in all samples. Values ranged between 37.0 and
57.85 in the dysphonic group and between 12.95 and 19.28 in the non-dysphonic group, with overall means of 46.09
and 15.55, respectively. High sensitivity and specificity were demonstrated when discriminating between the groups
with the following cut-off points: 22.50 (children), 29.25 (adult women), 22.75 (adult men), and 27.10 (seniors).
CONCLUSION: The protocol demonstrated high sensitivity and specificity in differentiating groups of individuals
with and without dysphonia in different sample groups and is thus an effective instrument for use in voice
clinics.
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’ INTRODUCTION
An essential component of the speech-language patholo-
gist’s voice assessment is the initial investigation, which, in
most cases, is designated as anamnesis. Here, a set of closed,
semi-open and/or open questions is administered to aid
clinicians in understanding the problem and its possible
causes (1-5). In a voice clinic, anamnesis can be decisive in
the differential diagnosis of dysphonia; in particular, it is
extremely important for understanding each case and also
provides the initial moment at which a bond is established
between the speech therapist and the patient (6).
The data from this initial investigation have been analyzed
in combination with data on other procedures, such as a
laryngological evaluation, auditory-perceptual and acoustic
voice analyses and a voice-related quality-of-life measure (3).
In contrast to the availability of models of voice-related
quality-of-life protocols in which the scores determine the impact
of dysphonia for a given individual (7,8), we did not find any
protocol for an initial investigation that allows for individual
assessment based on communication profile scores and that also
reveals the individual’s potential risk of developing a voice
disorder. The currently available questionnaires are mainly
restricted to the gathering of signs/symptoms and several risk
factors; among these, we highlight the Voice Symptom Scale (9)
and the Voice Capabilities Questionnaire (10).
In addition to assessing the signs and symptoms, other
aspects related to the communicative context, including
vocal self-perception using a visual analog scale (VAS) (11),
can extend the initial investigation to include screening for
the risk of dysphonia. Therefore, comprehensive anamnesis
would offer more consistent data for both the patient and the
professional; in addition, the inclusion of scores would
provide objective data, which can be more readily compared
with other variables. The calculation of scores also allows
expanded use of this assessment tool compared with other
conditions investigated in voice clinics.
A standardized and validated protocol with the calcula-
tion of a score would provide significant contributions to the
study of voice (12). In the context of health assistance, such a
protocol would allow classification of the patient’s prob-
ability of developing a given disorder and would present a
clearer contextualization of habits, signs and symptoms as
well as factors that interfere with the voice. As a result, the
use of a protocol can help the professional to determine the
best approaches in terms of guidance, treatment plans, and/
or patient follow-up in a more objective manner; it also
facilitates data sharing and discussion with the patient aboutDOI: 10.6061/clinics/2016(03)01
Copyright & 2016 CLINICS – This is an Open Access article distributed under the
terms of the Creative Commons License (http://creativecommons.org/licenses/by/
4.0/) which permits unrestricted use, distribution, and reproduction in any
medium or format, provided the original work is properly cited.
No potential conflict of interest was reported.
114
CLINICAL SCIENCE
his or her communicative context. In the research field, a protocol
allows for the comparison of results between different time
points and between different care services, in addition to offering
other voice assessment protocols and consistent data to guide
evidence-based practice (13). Furthermore, a protocol that can be
adapted to various languages and that facilitates cross-cultural
comparisons can provide relevant data for both the development
of activities promoting vocal well-being and for worldwide
epidemiological studies. Finally, this tool can serve as a teaching
instrument, thereby allowing for more systematic acquisition of
knowledge in the teaching environment (14).
The present study was performed to fabricate a proposal for
the study of voice that bridges the existing gap and that is also
effective in differentiating symptomatic and asymptomatic
individuals. Accordingly, the aim of this study was to propose
and test the applicability of the Dysphonia Risk Screening
Protocol (DRSP) with score calculation for individuals of
different age groups with and without vocal complaints.
’ METHODS
This cross-sectional study was approved by the home
institution’s ethics committee (CAPPEsq HCFMUSP 0560/10).
Sample
The participants were recruited from the larger group of
patients subjected to larynx examination at the Hospital das
Clínicas da Faculdade de Medicina da Universidade de São
Paulo (HCFMUSP), Ambulatório de Otorrinolaringologia,
during the study period. In addition, the persons accompany-
ing the patients and the professionals working in close
association with the medical team were invited to participate
both at the Hospital das Clínicas and at the Department of
Physiotherapy, Speech-language and Hearing Science and
Occupational Therapy, Faculdade de Medicina, Universidade
de São Paulo.
The patients with vocal complaints were recruited con-
comitantly with those without complaints and efforts were
made to maintain group pairings by gender and age. Upon
completion of the auditory-perceptual and acoustic voice
assessment described below, the presence or absence of voice
disorders was analyzed and the subjects were divided into a
dysphonic group (DG) and a non-dysphonic group (NDG).
Among the children and seniors, we chose to keep the
participants of both genders together within their groups due
to the anatomical and physiological similarities within each
age group.
Regarding the inclusion criteria, all patients who agreed to
participate in the study were included, regardless of their
laryngological diagnosis, gender and age.
Regarding the exclusion criteria, individuals with any
other impairments or diagnoses that might limit commu-
nication were excluded.
To assess the applicability and validity of the protocol, 365
subjects were enrolled in the study and were divided into
four sample groups (I - children, II - adult women, III - adult
men, and IV - seniors). The subjects were then further
divided as follows:
I - Of 41 children, 19 children (10 girls and 9 boys) with a
mean age of 7.5 years (±1.7) were allocated to the DG, and
22 children (11 boys and 11 girls) with a mean age of 8.5
years (±1.8) were allocated to the NDG.
II - Of 142 adult women, 74 women with a mean age of
41 years (±12.7) were allocated to the DG, and 68 women with
a mean age of 33.9 years (±12.6) were allocated to the NDG.
III - Of 91 adult men, 41 men with a mean age of 42.8 years
(±13.1) were allocated to the DG, and 50 men with a mean
age of 32.2 years (±12.2) were allocated to the NDG.
IV - Of 91 senior subjects, 54 (32 women and 22 men)
individuals with a mean age of 68.2 years (±6.2) were
allocated to the DG, and 37 (21 women and 16 men)
individuals with a mean age of 68.4 years (±7.1) were
allocated to the NDG.
Procedures
Step 1: The proposal presented here arose from the need to
standardize an initial investigation protocol for use in the
study of voice in teaching, research and the provision of care
in FMUSP Laboratory of Voice Research. Based on adaptation
of the protocol used in this laboratory, the goal was to expand
the proposed protocol to provide a tool that would enable
measurement via partial and total scores and that would have
the ability to indicate an individual’s risk of developing or
suffering from dysphonia. Based on various adjustments and
a pilot study with a sample of 15 patients, it was hypothesized
that higher partial and/or total scores would be indicative of
an increased risk of dysphonia and that lower scores would
indicate a lower risk thereof. In this sense, in the first stage
of the proposed general DRSP, the tool was effective in
differentiating subjects with vocal complaints/disorders from
individuals without voice complaints/disorders at different
ages (12).
In addition to the initial questions related to personal
identification, the final version of the protocol (Appendix 1)
contained 18 questions that could be answered by people of
any age, gender, level of education and use of voice. For the
score calculation, each response score ranged from 0 to 3,
with 0 representing a positive response and scores between 1
and 3 representing negative responses, ranging from least (1)
to most (3) negative. The exception to this scale was a VAS, in
which the value measured using a millimeter ruler was
added to the overall score. Each set of questions generated a
partial score and the sum of all scores yielded the total score.
The partial scores were related to the sub-items comprised
by the DRSP, including the following: VAS - self-assessment
of voice, with a value between 0 (no disorder) and 10
(maximum disorder), for which the value calculated with the
millimeter ruler was added to the final protocol value; PD -
previous voice disorders; SS - signs and symptoms; VOW - use
of voice outside of work; DI - diet; H - hydration; MD -
medications; S - contact with smokers; SL - sleep; ILL - history
of illness; FH - family history of vocal disorders; FD - family
dynamics; PA - physical activities; and LS - leisure. The
maximum total score was 131, which indicated an extreme
risk of dysphonia.
Step 2: The individuals who agreed to participate signed an
informed consent form and completed the DRSP. Speech
samples were then recorded using vocal tasks predefined in the
Brazilian Portuguese translation of the Consensus Auditory
Perceptual Evaluation-Voice (CAPE-V) (15). The recording was
performed in an acoustically treated room with noise levels
below 50 dB. The desktop computer used for recording and
processing was outfitted with Sound Forge Pro 10 software
(Sony Inc., Japan), an audio interface (UA-101 model, Edirol
by Roland, Australia), and a unidirectional condenser headset
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microphone (520 model, AKG, Germany). While recording the
vocal tasks, the microphone was placed at a distance of 3 to
5 cm from the individual’s mouth at an angle between 45o and
90o. Tests were performed to adjust the voice gain to avoid loss
of peaks or very weak sounds. The participant was instructed
to sit comfortably and to speak in a normal tone of voice.
Step 3: The vocal samples were classified according to the
overall degree (D) of vocal deviation using the CAPE-V
protocol to separate the NDG and DG; this evaluation was
always performed by the same speech therapist. This speech
therapist was a voice specialist with extensive experience in
auditory perceptual voice assessment and showed high intra-
rater reliability (intraclass correlation coefficient of 0.975).
All participants with complaints exhibited a certain degree of
disorder and were confirmed to belong to the DG. No parti-
cipants in the groups of women and men without complaints
showed any degree of dysphonia. In the groups of children and
senior subjects, those without complaints and with a mild level
of change were included in the NDG. A certain degree of vocal
disorder can be considered normal in childhood due to disorders
in the vocal tract in terms of position, size and tissue change,
which affect phonatory agility and flexibility (16,17). In seniors,
slight vocal disorders, even without vocal complaints, may be
related to physiological disorders, such as reduced vital res-
piratory capacity, maximum phonation time and muscle tone
and atrophy of the intrinsic muscles, associated with a decreased
muscular capacity to articulate speech sounds (18).
Step 4: To confirm the presence of disorders, the individuals
in the DG underwent laryngostroboscopy, which was per-
formed by the same team for 100% of the participants. The
procedure further confirmed the homogeneity of this group.
Different diagnoses were not considered in this study.
Step 5: All voice samples were analyzed using an acoustic
voice analysis to confirm the results obtained in the auditory-
perceptual analysis regarding the composition of the two
groups. This assessment was performed by the same speech
therapist six months after the auditory-perceptual analysis,
using sample recordings of sustained vowel sounds, as
described in Step 2. The recordings were arranged randomly
by the researcher in charge, who was blinded to the previous
analysis, all participant data (age, gender, diagnosis), and the
groups to which the participants belonged. The analysis was
performed using VoxMetria software (CTS Informática,
Brazil) and included extraction of the automatically mea-
sured jitter/period perturbation quotient (PPQ) (%), shim-
mer/extent perturbation quotient (EPQ) (%), correlation
value, irregularity, glottal-to-noise excitation (GNE) ratio
and noise. Moreover, the phonatory deviation diagram
(PDD) was considered with regard to the density (spread
or concentrated), shape (circular, horizontal, or vertical), and
quadrant (1 - normal, 2, 3, or 4 - altered) (19).
Calculation of the partial and total DRSP scores was
performed without any indication of the group to which the
participant belonged, and the presentation of the voices for
auditory-perceptual and acoustic analyses was performed
randomly for each evaluation. Similarly, the group to which
the subject belonged was not identified.
The statistical analysis consisted of descriptive measures
and the application of the Mann-Whitney and Chi-square tests
according to the types of variables to check for differences
between the DG and the NDG with respect to age, gender,
being or not being a professional voice user, VAS value, sub-
item partial scores and total score; the same tests were used to
verify the group divisions obtained based on the acoustic
analysis. A receiver operating characteristic (ROC) curve was
used to define cut-off points for the total score based on the
best sensitivity and specificity identified in each group. In this
study, the combined use of acoustic and auditory-perceptual
analyses was considered as the gold standard. A significance
level of 5% was adopted. It is worth noting that all
participants in the DG underwent laryngoscopy to confirm
the presence of voice disorders due to different laryngological
diagnoses.
Based on the laryngeal examination, DG patients showed
the following diagnoses (the respective absolute numbers
of women, men, seniors and children are presented): cysts
(11, 3, 2, 3), chorditis (1, 3, 2, 3), Reinke’s edema (11, 1,9,0),
incomplete glottal closure (4, 1, 0, 3), vocal fold leukoplakia
(4, 2, 8, 0), paradoxical vocal fold motion (1, 0, 0, 0), nodules
(7, 0, 0, 8), papilloma (2, 4, 3, 3), bilateral vocal fold palsy
(0, 0, 1, 0), unilateral vocal fold palsy (6, 5, 10, 1), polyps
(6, 15, 5, 0), mucosal bridge (1, 0, 0, 0), psychogenic
dysphonia (2, 0, 0, 0), laryngopharyngeal reflux (7, 1, 4, 0),
sulcus bilateral (6, 1, 2, 0), unilateral sulcus (2, 1, 2, 0), vocal
fold vascular lesions (1, 0, 0, 0), granuloma (0, 5, 1, 0),
Parkinson’s disease (0, 1, 0, 0), microweb (0, 0, 0, 1),
spasmodic dysphonia (0, 0, 1, 0) and presbylarynx (0, 0, 5, 0).
’ RESULTS
The gold standard for this study, which combined acoustic
and auditory-perceptual voice analyses performed at six-
month intervals in blinded samples, resulted in perfect
differentiation between the DG and the NDG. The acoustic
analysis was consistent with the findings of the auditory-
perceptual analysis, given that all of the aspects considered
equally separated the participants in the NDG and DG into
the four sample groups: jitter (o0.001), shimmer (o0.001),
the correlation value (o0.001), irregularity (o0.001), the
GNE ratio (0.025 to o0.001), noise (0.021 to o0.001) and
features of the PDD. Among the aspects considered in the
PDD (density, shape and quadrant), the third was the feature
with the highest statistical power, as 100% of the participants
in the NDG were classified in quadrant 1 and 100% of the
participants in the DG were placed in quadrant 2, 3, or 4.
Regarding the composition of the groups, age and gender
were homogeneous in the children’s and seniors’ groups
when comparing the DG and NDG. In the adult men’s and
women’s groups, tendencies toward higher age were
observed in the respective DGs.
Distribution into the DG and NDG according to the
classification of being a professional voice user was similar in
the women’s, men’s, and seniors’ groups. This parameter did
not apply in the children’s group.
There were differences in VAS self-assessment (po0.001)
between the DG and the NDG in all age groups, with an
overall mean score of 5.85 in the DG (Table 1).
Concerning the partial scores obtained according to the
protocol, differences were observed between the groups for
several of these scores, with greater values in the DG
compared with the NDG (Tables 1 and 2).
Regarding the partial score for previous voice disorders
(PD), greater means were observed in the DG in the children’s,
women’s, and men’s groups. There were no differences
between the DG and the NDG in the seniors’ group (Table 1).
Greater mean frequencies with which participants indicated
vocal signs and symptoms (SS) were observed in the DG
for all four sample groups (Table 1), with mean variations of
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18.9 (children) to 35.2 (women) in the DG and 4.6 (women) to
7.0 (seniors) in the NDG.
Regarding the use of voice outside of work/school (VOW),
greater scores were observed for the DG in the children’s
(p=0.002) and women’s (p=0.050) groups. There were no
differences in the men’s and seniors’ groups (Table 1).
In relation to dietary aspects that affect voice, there were
greater scores in the DG for both men (po0.001) and women
(po0.001). The DG and NDG had similar means in the
children’s and seniors’ groups (Table 1).
With regard to hydration, seniors in the DG had a greater
score than those in the NDG did (p=0.008). In contrast, in the
men’s, women’s and children’s groups, no differences were
observed (Table 1).
A greater mean was recorded for the use of medicines that
interfere with the voice for only the group of men in the DG
(p=0.048). None of the children used medication that affected
the voice and in the women’s and seniors’ groups, there were
no differences between the DG and the NDG (Table 2).
Greater contact with smokers (S) in the DG was observed
only for men. With regard to sleep (SL), all groups showed
similar means in the DG and NDG (Table 2). Regarding
history of illness (ILL), only the children’s group showed
similarity between the groups; in the other groups, the scores
in the DG were greater (po0.001) (Table 2).
The seniors’ group showed a tendency toward having
a family history of dysphonia (FH) and negative family
dynamics (FD) more often in the DG (p=0.080 and p=0.062,
Table 1 - Data distribution regarding partial Dysphonia Risk Screening Protocol scores (respective scores for visual analog scale,
previous voice disorders, signs and symptoms, use of voice outside of work, diet and hydration shown) for the four sample groups.
Analyzed aspect Groups Mean Median Standard deviation p value
VAS Children NDG 0.6 0.0 1.2 o0.001*
DG 5.9 6.0 3.0
Women NDG 0.8 0.0 1.1 o0.001*
DG 6.3 6.1 2.3
Men NDG 1.0 0.3 1.3 o0.001*
DG 5.0 5.0 2.6
Seniors NDG 1.5 1.8 1.9 o0.001*
DG 6.2 6.0 2.7
PD Children NDG 0.1 0.0 0.4 o0.001*
DG 1.0 1.0 0.9
Women NDG 0.0 0.0 0.2 o0.001*
DG 0.7 1.0 0.6
Men NDG 0.2 0.0 0.5 0.010*
DG 0.4 0.0 0.7
Seniors NDG 0.3 0.0 0.5 0.092
DG 0.5 0.0 0.6
SS Children NDG 4.9 4.5 4.5 o0.001*
DG 18.9 18.0 9.8
Women NDG 4.6 4.0 4.1 o0.001*
DG 35.2 33.0 16.1
Men NDG 5.0 3.0 4.9 o0.001*
DG 24.2 21.0 14.5
Seniors NDG 7.0 4.0 8.1 o0.001*
DG 29.4 26.0 13.7
VOW Children NDG 4.9 4.5 4.5 0.002*
DG 18.9 18.0 9.8
Women NDG 4.6 4.0 4.1 0.050*
DG 35.2 33.0 16.1
Men NDG 5.0 3.0 4.9 0.189
DG 24.2 21.0 14.5
Seniors NDG 7.0 4.0 8.1 0.159
DG 29.4 26.0 13.7
DI Children NDG 1.3 1.0 1.0 0.122
DG 2.0 2.0 1.5
Women NDG 1.7 2.0 1.3 o0.001*
DG 2.9 3.0 1.5
Men NDG 1.1 1.0 0.9 o0.001*
DG 2.2 2.0 1.1
Seniors NDG 2.3 2.0 1.4 0.954
DG 2.3 2.0 1.6
H Children NDG 1.5 2.0 0.9 0.504
DG 1.2 2.0 1.1
Women NDG 1.4 2.0 0.9 0.357
DG 1.8 2.0 2.7
Men NDG 0.7 0.0 1.0 0.251
DG 1.0 1.0 1.1
Seniors NDG 1.5 2.0 1.4 0.008*
DG 2.3 3.0 1.5
* Statistically significant; Mann-Whitney test
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respectively). Considering other ages and genders, the DG
and NDG were similar with respect to FH. The same pattern
was observed in the children’s and men’s groups for FD.
However, for this sub-item, the women’s DG presented
negative FD more often than those in the NDG (po0.001).
All groups were similar with respect to physical activity (PA).
The DG showed a tendency toward lower leisure frequencies for
both men (p=0.084) and seniors (p=0.052). In the children’s group,
both the DG and the NDG had the same leisure frequency.
The total scores revealed different means between the DG and
the NDG in all sample groups. In the DG in particular, values
ranged from 37.0 (children) to 57.85 (women) and in the NDG,
values ranged from 12.95 (men) to 19.28 (seniors) (Table 2). The
overall means were 46.09 in the DG and 15.55 in the NDG.
The ROC curves and total score cut-off points were
obtained based on the calculation of the protocol’s sensitivity
and specificity in discriminating between the DG and the
NDG (Figures 1-4) for each sample group. The following
were established:
I Children: 22.50 cut-off with a sensitivity of 0.947 and a
specificity of 0.955 (Figure 1).
II Adult women: 29.25 cut-off with a sensitivity of 0.959
and a specificity of 0.971 (Figure 2).
III Adult men: 22.75 cut-off with a sensitivity of 0.902 and a
specificity of 0.900 (Figure 3).
IV Seniors: 27.10 cut-off with a sensitivity of 0.907 and a
specificity of 0.865 (Figure 4).
’ DISCUSSION
The importance of testing a new tool for initial investigation
that encompasses anamnesis and self-assessment within a dys-
phonia risk screening protocol is based on the tool’s applicability
from clinical, teaching and research perspectives within the
study of voice. Studies have reported the use of anamnesis in
voice assessment, although the tool is often not administered.
Pereira et al. (4) specifically used a questionnaire consisting of
demographic (age, gender) and professional (working condi-
tions, weekly working hours and absenteeism, length of
employment) data, vocal symptoms (hoarseness, throat clearing,
dysphagia, difficulty singing, vocal fatigue, cough, neck ache,
difficulty in voice projection, loss of vocal power) and
comorbidities (nasal, gastroesophageal and auditory symptoms)
Table 2 - Data distribution regarding partial Dysphonia Risk Screening Protocol scores (respective scores for medications, contact with
smokers, sleep and history of illness shown) and total scores in the four sample groups.
Analyzed aspect Groups Mean Median Standard deviation p value
MD Children NDG 0.0 0.0 0.0 1.000
DG 0.0 0.0 0.0
Women NDG 0.4 0.0 0.4 0.557
DG 0.4 0.0 0.5
Men NDG 0.0 0.0 0.2 0.048*
DG 0.2 0.0 0.4
Seniors NDG 0.6 1.0 0.5 0.970
DG 0.6 1.0 0.5
S Children NDG 0.4 0.0 0.9 0.170
DG 1.1 0.0 1.4
Women NDG 0.5 0.0 0.8 0.091
DG 0.8 0.0 1.1
Men NDG 0.5 0.0 0.9 0.032*
DG 0.8 1.0 1.0
Seniors NDG 0.5 0.0 0.8 0.530
DG 0.6 0.0 0.9
SL Children NDG 0.3 0.0 0.6 0.210
DG 0.5 0.0 0.6
Women NDG 2.3 2.0 1.8 0.513
DG 2.5 2.0 1.8
Men NDG 0.9 1.0 1.0 0.101
DG 1.2 1.0 0.9
Seniors NDG 1.2 1.0 0.9 0.826
DG 1.1 1.0 1.0
ILL Children NDG 1.0 1.0 0.9 0.900
DG 1.0 1.0 0.9
Women NDG 0.8 0.0 1.0 o0.001*
DG 2.6 3.0 1.5
Men NDG 1.0 1.0 0.9 o0.001*
DG 2.0 2.0 1.2
Seniors NDG 1.4 1.0 1.3 o0.001*
DG 2.7 3.0 1.8
Total score Children NDG 13.9 13.0 6.4 o0.001*
DG 37.0 39.0 11.1
Women NDG 16.0 14.8 6.7 o0.001*
DG 57.8 57.2 18.9
Men NDG 12.9 11.0 6.7 o0.001*
DG 40.3 39.0 16.5
Seniors NDG 19.2 16.0 12.1 o0.001*
DG 49.2 48.2 17.1
* Statistically significant; Mann-Whitney test
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but did not detail the parameters of each item considered in their
research.
The standardization of tools using a scoring system allows
intra- and inter-institutional comparisons to be made, along
with cross-cultural research that can validate those compar-
isons. The voice handicap index (VHI) is a good example of
intercultural adaptation, as this index was translated,
adapted and validated in several languages (20-22). Simi-
larly, the comparison of a certain tool across different
populations or of various tools within the same sample
population can contribute to the advancement of an area of
knowledge (23).
In the groups of adult women and men in the current
study, the age of the participants in the DG was higher than
that in the NDG. It should be noted that many adult patients
delay seeking medical/speech therapy care. A recent study
of teachers and non-teachers with voice changes reported the
predominance of both genders in the 31- to 50-year-old age
group (4).
Both the DG and the NDG sample groups were homo-
geneous with respect to being a voice professional, which
eliminated a possible bias related to voice use.
When translating and adapting the children’s VHI into
Hebrew, Amir et al. (3) observed that during interviews, that
fathers and mothers similarly assessed the voices of children
with dysphonia, although mothers were more stringent.
In our study, parents could complete the DRSP for their
children together; however, mothers were more likely to
complete the DRSP because they accompanied their children
more often. All children with vocal complaints also
presented with auditory perceptual deviation, reflecting the
adequate perception of the parents.
Regarding seniors, even though those without voice
changes and those with mild changes were included in the
DG, all seniors without changes were further tested and
compared with seniors with changes, regardless of the
degree of the change (mild, moderate, or severe), there was
also differentiation between groups. It should be noted that
in seniors, slight disorders might not simply be due to
presbyphonia; such deviations could also be due to the onset
of neurological disease. These possible changes should be
examined and the DRSP is an instrument that is able to
detect such differences. In one patient referred for speech
therapy, initial investigation and vocal assessment data
contributed to the diagnosis of myasthenia gravis associated
with presbyphonia, which was the reason for referral (24).
Regarding the VAS-based voice self-assessment, all groups
exhibited perceptions of their voices that were compatible
with the study hypothesis, as the DG had greater means than
the NDG did. One of the innovations proposed in the present
study is the inclusion of the VAS in the questionnaire and the
addition of the VAS score to the overall score.
Women’s group
Diagnosis Abnormal Normal Total
≥29.25 71 2 73
<29.25 3 66 69
Total 74 68 142
Prevalence rate: 0.5211
False-negative rate: 0.0405
False-positive rate: 0.0294
Sensitivity: 0.9595
Specificity: 0.9706
Positive predictive value: 0.9726
Negative predictive value: 0.9565
Figure 2 - Receiver operating characteristic curve for the total Dysphonia Risk Screening Protocol scores for the women’s group.
Children’s group
Diagnosis Abnormal Normal Total
≥22.5 18 1 19
<22.5 1 21 22
Total 19 22 41
Prevalence rate: 0.4634
False-negative rate: 0.0526
False-positive rate: 0.0455
Sensitivity: 0.9474
Specificity: 0.9545
Positive predictive value: 0.9474
Negative predictive value: 0.9545
Figure 1 - Receiver operating characteristic curve for the total Dysphonia Risk Screening Protocol scores for the children’s group.
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Regarding a history of previous voice changes, Yamauchi
et al. (18) used high-speed laryngoscopy to compare healthy
vocal fold vibrations with the vibrations of vocal cords with
atrophy, revealing higher open quotients, greater lateral phase
differences and a greater integral glottal width in the latter
group. The authors noted that the incidence rates of voice
disorders in subjects with vocal fold atrophy are increasing
rapidly due to the aging of populations worldwide. These
observations do not necessarily relate to the use of the voice
throughout life and may explain the fact that the senior DG did
not present a history of previous voice changes more frequently
than the NDG did in the current study.
Regarding the frequency of vocal signs/symptoms, partial
scores were higher for the four DGs, consistent with previous
studies that have also considered frequency. Other Brazilian
studies have similarly reported significant differences between
groups with and without dysphonia (25,26).
In voice clinics, vocal signs/symptoms are included in the
first questionnaires given to the patient. Moreover, the
retrieval of such information is very frequent during screen-
ing and voice care programs and is achieved in many ways.
In particular, the literature describes the Voice Symptom
Scale (9) as a rigorous and psychometrically robust tool for vocal
self-assessment and provides information on the functional
effects, emotional impact and physical effects that a voice
problem may have on an individual’s life (26,27). The Voice
Capabilities Questionnaire (10) is also used to measure vocal
symptoms, but without implying that the respondent necessa-
rily has a voice disorder. The proposed DRSP falls within this
same line of investigation and offers the potential to survey
broader aspects of the voice. This assessment may be used in
individuals with or without dysphonia, with varying gradations
as to the potential risks of developing vocal disorders in the
latter case. The complex nature of voice assessment and the
need for appropriate tools, especially for functionally healthy
voice professionals, merit attention (28). Another aspect that
should be highlighted is the possibility of spontaneous inclusion
of other symptoms in the DRSP in addition to those listed.
Regarding the use of the voice outside of work/school
(VOW) in the present study, the higher scores in the DG for
the children’s and women’s groups were related to the
greater predisposition to the development of vocal nodules
in these populations, especially if associated with laryngeal
tension and vocal abuse (29).
The greater scores in the DG observed for the men’s and
women’s groups regarding dietary aspects related to the
voice draw attention to current sociocultural issues, wherein
a productive adult life, especially in large cities, has fostered
Seniors’ group
Diagnosis Abnormal Normal Total
≥27.1 49 5 54
<27.1 5 32 37
Total 54 37 91
Prevalence rate: 0.5934
False-negative rate: 0.0926
False-positive rate: 0.1351
Sensitivity: 0.9074
Specificity: 0.8649
Positive predictive value: 0.9074
Negative predictive value: 0.8649
Figure 4 - Receiver operating characteristic curve for the total Dysphonia Risk Screening Protocol scores for the seniors’ group.
Men’s group
Diagnosis Abnormal Normal Total
≥22.75 37 5 42
<22.75 4 45 49
Total 41 50 91
Prevalence rate: 0.4505
False-negative rate: 0.0976
False-positive rate: 0.1000
Sensitivity: 0.9024
Specificity: 0.9000
Positive predictive value: 0.8810
Negative predictive value: 0.9184
Figure 3 - Receiver operating characteristic curve for the total Dysphonia Risk Screening Protocol scores for the men’s group.
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the development of poor eating habits that affect health and
have possible vocal consequences. This finding corroborates
the high prevalence of voice disorders associated with lary-
ngopharyngeal reflux (30).
In the present study, hydration was present with greater
frequency in the NDG, though only for the seniors’ group.
A recent literature review indicated that although several
studies in the voice field suggest a relationship between
hydration and vocal function, there is a need for greater
understanding of this aspect to guide best practices in health
maintenance and the prevention of voice disorders (31).
The difference found for the men’s group in the current
study should be further investigated because the protocol
provides detailed information regarding the type and dosage
of drugs used, which is information that was not considered
here. Therefore, one should consider not only the medica-
tions prescribed to treat the clinical conditions that affect the
voice but also those that can increase the potential risk of
dysphonia (32,33).
The association detected between the presence of dyspho-
nia and greater contact with smokers in the men’s group in
this study requires further elucidation. Because the DRSP is
a general protocol designed for use by people of any age,
gender, or professional voice use status, it does not contain
questions regarding smoking itself; instead, these questions
appear in the supplementary DRSP, which is applicable only
to adults and seniors.
Regarding history of illness, the greater scores in all DGs
apart from the children’s DG may have been due to
comorbidities associated with dysphonia (30,33-35).
The relationship between negative family dynamics and
dysphonia in the women’s group corroborates the aspects
mentioned in relation to intense voice use and the greater
predisposition of this population to the development of vocal
nodules (29). This association also indicates the negative
emotional impact of family relationships in this group.
During analysis of the results, when the scores for
questions that did not differentiate between the DG and
the NDG across the four sample groups were removed
following calculation, the means continued to discriminate
the groups to similar degrees. Because these questions
involved qualitative aspects relevant to the communicative
context and because benefits were not observed following
their removal from the score, these questions were retained.
As a continuation of the present study, proposals to
supplement the DRSP with specific protocols for children, for
spoken and singing voice professionals and for adults and
seniors are under development. It is believed that the application
of both general and specific DRSPs will allow the gathering of
thorough knowledge about dysphonia risk for particular groups.
Based on the greater sensitivity and specificity values of
the DRSP in the four sample groups, it was possible to
establish cut-off points in the total scores; this further
reinforces the importance of the presented protocol for the
study of voice, not only in the clinic but also in health
promotion programs and in the field of epidemiology. The
protocol used will additionally enable the study of the
multiplicity of factors involved in the etiology of dysphonia.
The DRSP is therefore an instrument complementary
to auditory-perceptual, acoustic and physiological voice
evaluations. However, isolated analysis of this instrument
should be considered with caution.
It should be noted that patients under treatment at the
Laboratory of Voice/Speech Research at USP, with controls
employed before, during and after speech therapy, have
exhibited shifts in the therapeutic process based on DRSP
scores. For example, one patient with progressive worsening
of Parkinson’s disease presented a gradual increase in the
final DRSP score; in contrast, patients with initially high
scores have presented lower final scores. These results
encourage further studies to confirm this trend, with the
possibility of risk classification.
By employing score calculations and applying them to
different age groups, the DRSP was found to exhibit high
sensitivity and specificity in differentiating groups of
individuals with and without dysphonia.
The DRSP thus proved to be an effective instrument for
use in voice clinics.
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’ APPENDIX 1
DYSPHONIA RISK SCREENING PROTOCOL - GENERAL
Patient name: __________________________________________________________
Gender: M (0) F (1) RG: _____________Birthdate: ____/ _____/ _______ Age: _________
Nationality: _________________ Birthplace : _________________________________
Marital status: ______________Education:  ___________________________________
Address: __________________________________________________________________
Telephone: _____________________ e-mail:  ____________________________________
Occupation:_______________________________________________________________
___________________________________(0) Not voice professional; (1) Voice professional
Living with whom: __________________________________________________________
1. Why did you seek speech therapy in the field of voice?
____________________________________________________________________________
____________________________________________________________________________
________________________________________________________
2. On the scale below, indicate how much you believe your voice has changed, 
where 0 (zero) means no change and ten (10) means it has changed highly:
0 10
3. Has your voice undergone any changes previously?
(0) no (1) yes, once (2) yes, more than once; if so, describe the type of change, 
frequency and cause: 
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________________
4. Have you previously received treatment for your voice?
( ) no ( ) yes ; if so, describe the type, location, and time of treatment:  
____________________________________________________________________________
_____________________________________________________________________
VAS:
G:
O:
PD:
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5. Report the frequency with which the following items occur:
(Note: 3 - daily/always; 2 - weekly/almost always; 1 - monthly/sometimes; 0 - never)
(3) (2) (1) (0) vocal fatigue (3) (2) (1) (0) sore throat
(3) (2) (1) (0) itchy throat (3) (2) (1) (0) shortness of breath when speaking
(3) (2) (1) (0) hoarse throat (3) (2) (1) (0) stiff neck 
(3) (2) (1) (0) dry throat (3) (2) (1) (0) swollen neck 
(3) (2) (1) (0) burning throat (3) (2) (1) (0) choking 
(3) (2) (1) (0) throat clearing (3) (2) (1) (0) needing to cough to clear your throat 
(3) (2) (1) (0) pain opening and closing
your month 
(3) (2) (1) (0) reduced mouth opening 
(3) (2) (1) (0) easily biting your cheek (3) (2) (1) (0) pain in the shoulder girdle region 
(3) (2) (1) (0) fatigue after meals (3) (2) (1) (0) foreign body sensation in the larynx 
(3) (2) (1) (0) hoarseness (3) (2) (1) (0) weak voice 
(3) (2) (1) (0) voice stoppages or breaks (3) (2) (1) (0) voice becoming deeper
(3) (2) (1) (0) excess air in the voice (3) (2) (1) (0) voice 
becoming more highly pitched 
(3) (2) (1) (0) vocal tremor
(3) (2) (1) (0) difficulty in controlling vocal intensity 
(3) (2) (1) (0) other(s): ________________________________________________________
__________________________________________________________________________
6. Use of voice outside of work:
. do you usually shout?  (0) no (1) yes
. do you usually talk a lot? (0) no (1) yes
. do you usually speak loudly? (0) no (1) yes
. do you imitate other voices? (0) no (1) yes
. do you use your voice in religious and/or sporting activities? (0) no (1) yes; if so, 
please describe: 
____________________________________________________________________________
___________________________________________________________________
7. Diet:
. do you consider your diet to be nutritionally balanced? (0) yes (1) no
. do you consider it well balanced with regard to consistency? (0) yes (1) no
. do you go to bed at least 2 hours after the last meal of the day? 
SS:
VOW:
DI:
(0) yes (1) no
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. do you have difficulty chewing and/or swallowing? (0) no (1) yes; if so, please 
describe:
___________________________________________________________________
___________________________________________________________________
. do you eat anything that causes vocal disorders?  (0) no (1) yes; if so, please describe: 
_____________________________________________________________________
_____________________________________________________________________
. do you eat any food for the purpose of improving your voice (e.g., honey, ginger, teas, 
tablets, etc.)? (0) no (1) yes; if so, please describe: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
. do you drink coffee several times a day? (0) no (1) yes; if so, describe the amount and 
frequency: 
_____________________________________________________________________
_____________________________________________________________________
8. Hydration:
. do you drink water during the day? (0) yes, more than six cups or more than 1.5 L (2) 
six cups or less, or 1.5 L or less (3) no; if so, describe the exact amount, frequency,
and situations: _________________________________________________________
_____________________________________________________________________
. do you drink other liquids (juices and herbal teas, except tea)? (0) yes (1) no; if so, 
describe the type, amount , and frequency:
______________________________________________________________________
______________________________________________________________________
9. Do you regularly use any kind of medication?
( ) no ( ) yes; if so, describe the name, frequency, amount,and reason: 
_______________________
______________________________________________________________________
__________________________________________________________________________________
(0) never affects negatively voice (1) at least one affects negatively voice (2) more than one affects negatively voice
H:
MD:
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10. Do you have contact with smokers?
(0) no (1) sporadic (3) daily; if so, describe exact frequency and situations: 
____________________________________________________________________________
11. Sleep:
11.1. Average number of hours of sleep per night: __________ (0) 7 hours or more (1) less than 7 
hours
11.2. Do you wake up rested? (0) yes (1) no
11.3. Do you have any kind of sleep disorder (e.g., insomnia, apnea, bruxism, etc.)?
(0) no (1) yes; if so, describe: ______________________________________
12. History of illness:
. do you have frequent colds? (0) no (1) yes
. do you have allergies?   (0) no (1) yes
. do you have hearing problems? (0) no (1) yes; if so, please describe: 
________________________________________________________________
. do you have dental problems? (0) no (1) yes; if so, please describe: 
________________________________________________________________
. do you have temporomandibular dysfunction?   (0) no (1) yes
. do you have gastroesophageal reflux? (0) no (1) yes
. do you have any other illnesses?  (0) no (1) yes; if so, please describe: 
____________________________________________________________________________
_____________________________________________________________________
13. History of treatment and surgeries:
____________________________________________________________________________
_____________________________________________________________________
14. Do any family members have voice problems?
(0) no (1) yes; if so, describe kinship, observed disorder, and treatments performed: 
____________________________________________________________________________
___________________________________________________________________________________
S:
SL:
ILL:
FH:
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15. Briefly describe your family dynamics and relationships with family 
members :
____________________________________________________________________________
___________________________________________________________________________________
_____________________________________________________________
(0) positive tendency (1) negative tendency
16. Do you practice regular physical activity?
(1) no (0) yes; if so, describe: ___________________________________________
_________________________________________________________________
17. Describe your leisure activities (type and frequency):
____________________________________________________________________________
__________________________________________________________________
(0) frequent leisure activities (1) no leisure activities
18. Other relevant comments:
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Prior ENT Diagnosis (if any): _________________________________________
______________________________________________________________________
____________________________________ Assessment date: _____/_____/_______
Location: _______________________________________________________________
FD:
PA:
LS:
FINAL SCORE: _____________
Reference scores for cut-off (below the cut-off values considered 
low risk of dysphonia, above the cut-off values considered high 
risk of dysphonia):
Children 22.50
Adult Women 29.25
Adult Men 22.75
Seniors 27.10
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ENT HC diagnosis: ____________________________________________________________________
____________________________________________________________________________________
__________________________________________________ Assessment date: _____/_____/_______
Date: _____/_____/________                                 Trainee : ____________________________________
Speech therapist: ______________________________
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